Literature DB >> 10980845

Fibrates and high-dose statins to prevent coronary heart disease events.

P H Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10980845     DOI： 10.1007/s11886-999-0026-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  5 in total

Review 1.  Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis.

Authors:  H N Hodis
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

2.  Statin trials and goals of cholesterol-lowering therapy.

Authors:  S M Grundy
Journal:  Circulation       Date:  1998-04-21       Impact factor: 29.690

3.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

Authors:  B Pitt; D Waters; W V Brown; A J van Boven; L Schwartz; L M Title; D Eisenberg; L Shurzinske; L S McCormick
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

Review 4.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

Review 5.  Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

Authors:  R S Rosenson; C C Tangney
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.